Annual Total Debt
$9.16 M
-$1.36 M-12.96%
December 31, 2023
Summary
- As of March 13, 2025, NRXPW annual total debt is $9.16 million, with the most recent change of -$1.36 million (-12.96%) on December 31, 2023.
- During the last 3 years, NRXPW annual total debt has risen by +$8.36 million (+1049.44%).
- NRXPW annual total debt is now -12.96% below its all-time high of $10.53 million, reached on December 31, 2022.
Performance
NRXPW Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$6.67 M
-$982.00 K-12.83%
September 30, 2024
Summary
- As of March 13, 2025, NRXPW quarterly total debt is $6.67 million, with the most recent change of -$982.00 thousand (-12.83%) on September 30, 2024.
- Over the past year, NRXPW quarterly total debt has stayed the same.
- NRXPW quarterly total debt is now -33.77% below its all-time high of $10.07 million, reached on September 30, 2023.
Performance
NRXPW Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
NRXPW Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -13.0% | 0.0% |
3 y3 years | +1049.4% | - |
5 y5 years | +496.6% | - |
NRXPW Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -13.0% | +1668.5% | -33.8% | +1187.5% |
5 y | 5-year | -13.0% | +1668.5% | -33.8% | >+9999.0% |
alltime | all time | -13.0% | +1668.5% | -33.8% | >+9999.0% |
NRx Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $6.67 M(-12.8%) |
Jun 2024 | - | $7.65 M(+12.9%) |
Mar 2024 | - | $6.78 M(-26.0%) |
Dec 2023 | $9.16 M(-13.0%) | $9.16 M(-9.0%) |
Sep 2023 | - | $10.07 M(+1836.3%) |
Dec 2022 | $10.53 M(+1931.9%) | - |
Mar 2022 | - | $520.00 K(+0.4%) |
Dec 2021 | $518.00 K | $518.00 K(+0.6%) |
Sep 2021 | - | $515.06 K(-24.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2021 | - | $686.17 K(>+9900.0%) |
Dec 2020 | $797.00 K(-48.1%) | $1809.89(>+9900.0%) |
Sep 2020 | - | $1.69(-100.0%) |
Jun 2020 | - | $685.48 K(+24.9%) |
Mar 2020 | - | $548.79 K(-64.3%) |
Dec 2019 | $1.54 M | $1.54 M(+369.3%) |
Sep 2019 | - | $327.20 K(+58.2%) |
Jun 2019 | - | $206.87 K(-86.1%) |
Mar 2019 | - | $1.49 M |
FAQ
- What is NRx Pharmaceuticals annual total debt?
- What is the all time high annual total debt for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual total debt year-on-year change?
- What is NRx Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly total debt year-on-year change?
What is NRx Pharmaceuticals annual total debt?
The current annual total debt of NRXPW is $9.16 M
What is the all time high annual total debt for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual total debt is $10.53 M
What is NRx Pharmaceuticals annual total debt year-on-year change?
Over the past year, NRXPW annual total debt has changed by -$1.36 M (-12.96%)
What is NRx Pharmaceuticals quarterly total debt?
The current quarterly total debt of NRXPW is $6.67 M
What is the all time high quarterly total debt for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly total debt is $10.07 M
What is NRx Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, NRXPW quarterly total debt has changed by $0.00 (0.00%)